Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments

Chemotherapy

Volumn 57, Issue 6, 2012, Pages 497-504

  Sowunmi, Akintunde ^a,b   Okuboyejo, Titilope M ^a   Gbotosho, Grace O ^a   Happi, Christian T ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Artemisinin based combination treatments; Children; Gametocyte carriage; Nigeria; Risk factors

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; FOLLOW UP; GAMETOCYTAEMIA; GAMETOCYTE; HEMATOCRIT; HUMAN; INFANT; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; AMINOQUINOLINES; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; RISK FACTORS;

EID: 84855874553     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000334126     Document Type: Article

References (44)

1. Sinden RE, Canning EU, Bray RS, Smalley ME: Gametocyte and gamete development in Plasmodium falciparum. Proc R Soc Lond B Biol Sci 1978; 201: 375-399. (Pubitemid 8360143)
2. Carter R, Graves PM: Gametocytes; in Wernsdorfer WH, McGregor I (eds): Malaria. Principles and Practice of Malariology. Edinburgh, Churchill Livingstone, 1988, vol 1, pp 253-306.
3. Carter P, Miller LH: Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull World Health Org 1979; 57(suppl 1):37-52. (Pubitemid 10110792)
4. Butcher GA: Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 1997; 27: 975-987. (Pubitemid 27423685)
5. Buckling A, Ranford-Cartwright LC, Miles A, Read AF: Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology 1999; 118: 339-346. (Pubitemid 29186944)
6. von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G: Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 2001; 65: 523-526.
7. Bousema JT, Schneider P, Gougna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW: Moderate effect of artemisininbased combination therapy on transmission of Plasmodium falciparum. J Infect Dis 2006; 193: 1151-1159.
8. Sowunmi A, Balogun T, Gbotosho GO, Happi CT, Adedeji AA, Bolaji OM, Fehintola FA, Folarin OA: Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual stage parasites in falciparum malaria in children. Chemotherapy 2008; 54: 201-208. (Pubitemid 351929271)
9. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT: Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs. Acta Trop 2009; 109: 108-117.
10. Tripathi R, Khanna M, Dwivedi AK: Efficacy of novel oral formulations of β artemether against multi-drug resistant malaria in mice. Chemotherapy 2010; 56: 178-183.
11. Fujishima T, Nishise S, Ichihara M, Kobayashi S, Takeuchi T: Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan Chemotherapy 2010; 348-352.
12. Federal Ministry of Health: National Malaria Treatment Policy. Abuja, Nigeria, 2004.
13. Federal Ministry of Health: National Antimalarial Treatment Guidelines. Abuja, Nigeria, 2005.
14. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Happi TC: Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology 2004; 129: 255-262. (Pubitemid 39265607)
15. Salako LA, Ajayi FO, Sowunmi A, Walker O: Malaria in Nigeria: a revisit. Ann Trop Med Parasitol 1990; 84: 435-445. (Pubitemid 20384405)
16. Sowunmi A, Gbotosho GO, Happi CT, Adedeji AA, Fehintola FA, Folarin OA, Tambo E, Fateye BA: Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. Am J Trop Med Hyg 2007; 77: 235-241. (Pubitemid 351859269)
17. Sowunmi A, Balogun T, Gbotosho GO, Happi CT, Adedeji AA, Fehintola FA: Activities of amodiaquine, artesunate, and artesunateamodiaquine against asexual-and sexualstage parasites in falciparum malaria in children. Antimicrob Agents Chemother 2007; 51: 1694-1699. (Pubitemid 46744147)
18. Sowunmi A, Gbotosho GO, Happi C, Okuboyejo T, Folarin O, Balogun S, Michael O: Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria. Am J Trop Med Hyg 2009; 81: 979-986.
19. Michael OS, Gbotosho GO, Folarin OA, Okuboyejo T, Sowunmi A, Oduola AMJ, Happi CT: Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance. Malar J 2010; 9: 335.
20. Gbotosho GO, Sowunmi A, Okuboyejo TM, Happi CT, Folarin OO, Adewoye EO: A simple dosing regimen of artesunate and amodiaquine based on age or body weight range for uncomplicated falciparum malaria in children: comparison of therapeutic efficacy with standard dose regimen of artesunate and amodiaquine and artemether-lumefantrine. Am J Therap 2011, Epub ahead of print.
21. Gbotosho GO, Sowunmi A, Okuboyejo TM, Happi CT, Folarin OA, Michael OS, Adewoye EO: Therapeutic efficacy and effects of artemether-lumefantrine and artesunateamodiaquine co-formulated or co-packaged, on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria. Am J Trop Med Hyg 2011; 84: 813-819.
22. World Health Organization: Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(suppl 1):1-90.
23. Shaper AG, Lewis P: Genetic neutropenia in people of African origin. Lancet 1971;ii:1021-1023.
24. Ezeilo GC: Neutropenia in Africans. Trop Geogr Med 1971; 23: 264-267.
25. Sowunmi A, Akindele JA, Balogun MA: Leukocyte counts in falciparum malaria in African children from an endemic area. Afr J Med Med Sci 1995; 24: 145-149.
26. World Health Organization: Chemotherapy of Malaria and Resistance to Antimalarials. Technical Report Series No. 529. WHO, Geneva, 1973.
27. World Health Organization: Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. WHO/HTM/RBM/ 2003.50. Geneva, WHO, 2003.
28. White NJ: Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 1997; 41: 1413-1422. (Pubitemid 27289660)
29. Epi Info, Version 6. A Word-Processing, Database, and Statistics Program for Public Health on IBM-Compatible Microcomputers. Atlanta, Centers for Disease Control and Prevention, 1994.
30. SPSS for Windows, Release 10.01 (standard version). Chicago, SPSS, 1999.
31. Mons B: Induction of sexual differentiation in malaria. Parasitol Today 1985; 1: 87-89.
32. Akim NIJ, Drakeley C, Kingo T, Simon B, Senkoro K, Sauerwein RW: Dynamics of Plasmodium falciparum gametocytaemia in symptomatic patients in an area of intense perennial transmission in Tanzania. Am J Trop Med Hyg 2000; 63: 199-203. (Pubitemid 32488360)
33. Price R, Nosten F, Sinpson JA, Luxemburger C, Paiphun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ: Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 1999; 60: 1019-1023. (Pubitemid 29296230)
34. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akin INJ, Beier JC, Githure JI, Sauerwein RW: Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 2004; 3: 18.
35. Kumar N, Zheng H: Stage-specific gametocytocidal effect in vitro of the antimalarial drug quinghaosu on Plasmodium falciparum. Parasitol Res 1990; 76: 214-218. (Pubitemid 20116097)
36. Mockenhaupt FP, Falusi AG, May J, Ademowo OG, Olumese PE, Meyer CG, Bienzle U: The contribution of + thalassaemia to anaemia in a Nigerian population exposed to intense malaria transmission. Trop Med Int Health 1999; 4: 302-307. (Pubitemid 29217437)
37. Crawley J: Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa. Am J Trop Med Hyg 2004; 71(suppl 2):25-34. (Pubitemid 39121301)
38. Nacher M, Singhasivanon P, Silachamroon U, Treeprasertsuk S, Tosukhowong T, Vannaphan S, Gay F, Mazier D, Looareesuwan S: Decreased hemoglobin concentrations, hyperparasitemia and severe malaria are associated with increased Plasmodium falciparum gametocyte carriage. J Parasitol 2002; 88: 97-101. (Pubitemid 34250637)
39. Sowunmi A, Gbotosho GO, Happi CT, Fateye BA: Factors contributing to anaemia in uncomplicated Plasmodium falciparum malaria in children. Acta Trop 2009; 113: 155-161.
40. World Health Organization: The Use of Antimalarial Drugs. Report of a WHO Informal Consultation. WHO/CDS/RBM/ 2001.33. Geneva, WHO, 2001.
41. World Health Organization: The Use of Antimalarial Drugs. Report of a WHO Informal Consultation. WHO/CDS/RBM/ 2001.35. Geneva, WHO, 2001.
42. Carrara VI, Zwang J, Ashley AA, Price RN, Stepniewska, K, Brends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F: Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 2009; 4:e4551.
43. Oduola AMJ, Sowunmi A, Milhous WK, Kyle DE, Martin SK, Walker O, Salako LA: Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg 1992; 86: 123-127.
44. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ: Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 2008; 7: 125.